On a current yield of 5.3%, does AstraZeneca have what it takes to make it into our special report “5 Shares To Retire On“? To find out the names of the five shares, and the reasons behind their inclusion, simply click here to have it delivered free to your inbox.
https://youtu.be/JnGcU8Kc1XM
Should you buy AstraZeneca Plc shares today?
Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from Trump's tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.
That's why this could be an ideal time to secure this valuable research – Mark's analysts have scoured the markets to reveal 5 of his favourite long-term 'Buys'. Please, don't make any big decisions before seeing them.
In this video series, Owain Bennallack take a look at some of the best routes within the FTSE 100 to gain from the growth of emerging markets. Under the spotlight this time is AstraZeneca (LSE: AZN) (NYSE: AZN.US).